The m6A RNA modifications and their regulators—including METTL3, ALKBH5, FTO, YTHDFs, hnRNPA2B1, and IGF2BP2—have particularly emerged as key drivers of chemotherapy resistance in gastric cancer [86,94,122]. Here, IGF2BP2 is linked to gastric cancer.